Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: The next step forward or two steps back?

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 3-12

  Beverly, Levi J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Apoptosis; BCL2; BH3; Mitochondria; MOMP

Indexed keywords

BH3 PROTEIN; PROTEIN BCL 2;

APOPTOSIS; CELL FUNCTION; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 84055212651     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23335     Document Type: Review

References (78)

1. Adams JM, Cory S,. 1998. The Bcl-2 protein family: Arbiters of cell survival. Science 281 (5381): 1322-1326. (Pubitemid 28406819)
2. Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G,. 1999. Presenilin 1 protein directly interacts with Bcl-2. J Biol Chem 274: 30764-30769.
3. Ayllón V, Cayla X, García A, Roncal F, Fernández R, Albar JP, Martínez C, Rebollo A,. 2001. Bcl-2 targets protein phosphatase 1 alpha to Bad. J Immunol 166 (12): 7345-7352. (Pubitemid 32525610)
4. Ayllón V, Cayla X, García A, Fleischer A, Rebollo A,. 2002. The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad. Eur J Immunol 32 (7): 1847-1855. (Pubitemid 34822814)
5. Bae J, Donigian JR, Hsueh AJW,. 2003. Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis. J Biol Chem 278 (7): 5195-5204. (Pubitemid 36801032)
6. Beverly LJ, Varmus HE,. 2009. MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family. Oncogene 28 (9): 1274-1279.
7. Bruey J-M, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S-i, Terskikh AV, Faustin B, Reed JC,. 2007. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129: 45-56. (Pubitemid 46507581)
8. Chau BN, Cheng EH, Kerr DA, Hardwick JM,. 2000. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 6 (1): 31-40.
9. Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, Berridge MJ, Conway SJ, Holmes AB, Mignery GA, Velez P, Distelhorst CW,. 2004. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol 166: 193-203. (Pubitemid 38988772)
10. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM,. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278 (5345): 1966-1968. (Pubitemid 28013242)
11. Cheng A, Arumugam TV, Liu D, Khatri RG, Mustafa K, Kwak S, Ling H-P, Gonzales C, Xin O, Jo D-G, Guo Z, Mark RJ, Mattson MP,. 2007. Pancortin-2 interacts with WAVE1 and Bcl-xL in a mitochondria-associated protein complex that mediates ischemic neuronal death. J Neurosci 27: 1519-1528. (Pubitemid 46280083)
12. Combet CBC, Geourjon C, Deleage C,. 2000. NPS@: Network Protein Sequence Analysis. TIBS 25 (3): 147-150. (Pubitemid 30122428)
13. Coovert DD, Le TT, Morris GE, Man NT, Kralewski M, Sendtner M, Burghes AH,. 2000. Does the survival motor neuron protein (SMN) interact with Bcl-2? J Med Genet 37 (7): 536-539. (Pubitemid 30428243)
14. Cory S, Huang DC, Adams JM,. 2003. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 22 (53): 8590-8607. (Pubitemid 38028528)
15. Deng X, Ito T, Carr B, Mumby M, May WS,. 1998. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J Biol Chem 273 (51): 34157-34163. (Pubitemid 29008888)
16. Du YC, Lewis BC, Hanahan D, Varmus H,. 2007. Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion. PLoS Biol 5 (10): e276.
17. Fernandez-Sarabia MJ, Bischoff JR,. 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature 366 (6452): 274-275. (Pubitemid 23359711)
18. Fujise K, Zhang D, Liu J, Yeh ET,. 2000. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem 275 (50): 39458-39465. (Pubitemid 32058971)
19. Gil-Parrado S, Fernández-Montalván A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Reed JC, Fritz H, Fuentes-Prior P, Spiess E, Salvesen GS, Machleidt W,. 2002. Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem 277: 27217-27226. (Pubitemid 34951738)
20. Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW,. 2006. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 26 (34): 8774-8786. (Pubitemid 44319413)
21. Guillemin Y, Lalle P, Gillet G, Guerin J-F, Hamamah S, Aouacheria A,. 2009. Oocytes and early embryos selectively express the survival factor BCL2L10. J Mol Med 87 (9): 923-940.
22. Ha S, Lee S, Chung M, Choi Y,. 2002. Mouse ING1 homologue, a protein interacting with A1, enhances cell death and is inhibited by A1 in mammary epithelial cells. Cancer Res 62 (5): 1275-1278. (Pubitemid 34407777)
23. Harley ME, Allan LA, Sanderson HS, Clarke PR,. 2010. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 29 (14): 2407-2420.
24. Horvitz HR,. 1999. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 59 (7 Suppl): 1701s-1706s. (Pubitemid 29165241)
25. Hu Y, Benedict MA, Wu D, Inohara N, Núñez G,. 1998. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95 (8): 4386-4391.
26. Hu ZB, Minden MD, McCulloch EA, Stahl J,. 2000. Regulation of drug sensitivity by ribosomal protein S3a. Blood 95 (3): 1047-1055. (Pubitemid 30062730)
27. Huang DC, Strasser A,. 2000. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103 (6): 839-842.
28. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y,. 1997. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390 (6658): 413-417. (Pubitemid 28027324)
29. Jin Z, Gao F, Flagg T, Deng X,. 2004. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem 279 (38): 40209-40219. (Pubitemid 39258297)
30. Kohl TM, Hellinger C, Ahmed F, Buske C, Hiddemann W, Bohlander SK, Spiekermann K,. 2007. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts. Leukemia 21 (8): 1763-1772. (Pubitemid 47086765)
31. Komatsu K, Miyashita T, Hang H, Hopkins KM, Zheng W, Cuddeback S, Yamada M, Lieberman HB, Wang HG,. 2000. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol 2 (1): 1-6.
32. Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, Verhaegen M, Soengas M, Ruvolo VR, McQueen T, Schober WD, Watt JC, Jiffar T, Ling X, Marini FC, Harris D, Dietrich M, Estrov Z, McCubrey J, May WS, Reed JC, Andreeff M,. 2006. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10: 375-388. (Pubitemid 44693472)
33. Kurschner C, Morgan JI,. 1995. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res Mol Brain Res 30 (1): 165-168.
34. Lanave C, Santamaria M, Saccone C,. 2004. Comparative genomics: The evolutionary history of the Bcl-2 family. Gene 333: 71-79. (Pubitemid 38737353)
35. Levine B, Sinha S, Kroemer G,. 2008. Bcl-2 family members: Dual regulators of apoptosis and autophagy. Autophagy 4 (5): 600-606.
36. Li QM, Tep C, Yune TY, Zhou XZ, Uchida T, Lu KP, Yoon SO,. 2007. Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury. J Neurosci 27 (31): 8395-8404. (Pubitemid 47219616)
37. Lin B, Kolluri SK, Lin F, Liu W, Han Y-H, Cao X, Dawson MI, Reed JC, Zhang X-K,. 2004. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (4): 527-540. (Pubitemid 38264430)
38. Liu H, Peng H-W, Cheng Y-S, Yuan HS, Yang-Yen H-F,. 2005. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 25 (8): 3117-3126. (Pubitemid 40464314)
39. Lo S-C, Hannink M,. 2006. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 281 (49): 37893-37903. (Pubitemid 46042093)
40. Luciano F, Krajewska M, Ortiz-Rubio P, Krajewski S, Zhai D, Faustin B, Bruey JM, Bailly-Maitre B, Lichtenstein A, Kolluri SK, Satterthwait AC, Zhang XK, Reed JC,. 2007. Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma. Blood 109: 3849-3855. (Pubitemid 46641736)
41. Makishima T, Yoshimi M, Komiyama S, Hara N, Nishimoto T,. 2000. A subunit of the mammalian oligosaccharyltransferase, DAD1, interacts with Mcl-1, one of the bcl-2 protein family. J Biochem 128 (3): 399-405.
42. Mancini F, Conza GD, Pellegrino M, Rinaldo C, Prodosmo A, Giglio S, Apos D, Agnano I, Florenzano F, Felicioni L, Buttitta F, Marchetti A, Sacchi A, Pontecorvi A, Soddu S, Moretti F,. 2009. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. Embo J 28: 1926-1939.
43. Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H,. 2002. p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 62 (10): 2883-2889. (Pubitemid 34525775)
44. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM,. 2003. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11 (3): 577-590. (Pubitemid 36385115)
45. Moriishi K, Huang DC, Cory S, Adams JM,. 1999. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci USA 96 (17): 9683-9688. (Pubitemid 29398792)
46. Nakagawa T, Yuan J,. 2000. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150 (4): 887-894. (Pubitemid 30663424)
47. Naumovski L, Cleary ML,. 1996. The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M. Mol Cell Biol 16 (7): 3884-3892. (Pubitemid 26199908)
48. Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, Shore GC,. 1997. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 139 (2): 327-338. (Pubitemid 27459307)
49. Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, Murthy Madiraju SR, Goulet D, Viallet J, Bélec L, Billot X, Acoca S, Purisima E, Wiegmans A, Cluse L, Johnstone RW, Beauparlant P, Shore GC,. 2007. Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 104: 19512-19517.
50. Olivier R, Otter I, Monney L, Wartmann M, Borner C,. 1997. Bcl-2 does not require Raf kinase activity for its death-protective function. Biochem J 324 (Pt 1): 75-83. (Pubitemid 27229368)
51. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH,. 2005. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681. (Pubitemid 40825512)
52. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH,. 2004. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43 (1): 19-30. (Pubitemid 38952816)
53. Passer BJ, Pellegrini L, Vito P, Ganjei JK, D'Adamio L,. 1999. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. J Biol Chem 274 (34): 24007-24013.
54. Pathan N, Aime-Sempe C, Kitada S, Basu A, Haldar S, Reed JC,. 2001. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia 3 (6): 550-559. (Pubitemid 33151022)
55. Poulaki V, Mitsiades N, Romero ME, Tsokos M,. 2001. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res 61 (12): 4864-4872. (Pubitemid 32691903)
56. Rebollo A, Ayllón V, Fleischer A, Martínez CA, Zaballos A,. 2001. The association of Aiolos transcription factor and Bcl-xL is involved in the control of apoptosis. J Immunol 167 (11): 6366-6373. (Pubitemid 33081568)
57. Reed JC,. 2006. Drug insight: Cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nature Clin Pract Oncol 3 (7): 388-398. (Pubitemid 44027293)
58. Schmitt E, Beauchemin M, Bertrand R,. 2007. Nuclear colocalization and interaction between bcl-xL and cdk1(cdc2) during G2/M cell-cycle checkpoint. Oncogene 26 (40): 5851-5865.
59. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O'rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DCS, Dixit VM,. 2010. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463: 103-107.
60. Shimizu S, Konishi A, Kodama T, Tsujimoto Y,. 2000. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA 97 (7): 3100-3105. (Pubitemid 30183262)
61. Shirane M, Nakayama KI,. 2003. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5 (1): 28-37. (Pubitemid 36054326)
62. Shoemaker AR, Mitten MJ, Adickes J, Ackler S, Refici M, Ferguson D, Oleksijew A, O'Connor JM, Wang B, Frost DJ, Bauch J, Marsh K, Tahir SK, Yang X, Tse C, Fesik SW, Rosenberg SH, Elmore SW,. 2008. Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models. Clin Cancer Res 14: 3268-3277.
63. Song D, Sakamoto S, Taniguchi T,. 2002. Inhibition of poly(ADP-ribose) polymerase activity by Bcl-2 in association with the ribosomal protein S3a. Biochemistry 41 (3): 929-934. (Pubitemid 34061995)
64. Sorenson CM, Sheibani N,. 1999. Focal adhesion kinase, paxillin, and bcl-2: Analysis of expression, phosphorylation, and association during morphogenesis. Dev Dyn 215 (4): 371-382. (Pubitemid 29377205)
65. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y,. 2000. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19 (50): 5736-5746.
66. Tamura Y, Simizu S, Osada H,. 2004. The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 569 (1-3): 249-255. (Pubitemid 38844627)
67. Tamura Y, Simizu S, Muroi M, Takagi S, Kawatani M, Watanabe N, Osada H,. 2009. Polo-like kinase 1 phosphorylates and regulates Bcl-x(L) during pironetin-induced apoptosis. Oncogene 28 (1): 107-116.
68. Tsujimoto Y,. 1998. Role of Bcl-2 family proteins in apoptosis: Apoptosomes or mitochondria? Genes Cells 3 (11): 697-707. (Pubitemid 29038090)
69. Ueno H, Kondo E, Yamamoto-Honda R, Tobe K, Nakamoto T, Sasaki K, Mitani K, Furusaka A, Tanaka T, Tsujimoto Y, Kadowaki T, Hirai H,. 2000. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function. Mol Biol Cell 11: 735-746. (Pubitemid 30112178)
70. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey L, Troppmair J, Rapp UR,. 1994. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9 (9): 2751-2756. (Pubitemid 24254056)
71. Weng C, Li Y, Xu D, Shi Y, Tang H,. 2005. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem 280 (11): 10491-10500. (Pubitemid 40395908)
72. Yamamoto K, Ichijo H, Korsmeyer SJ,. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19 (12): 8469-8478. (Pubitemid 30414041)
73. Yanagisawa H, Miyashita T, Nakano Y, Yamamoto D,. 2003. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ 10 (7): 798-807. (Pubitemid 36850241)
74. Yang Y, Yang F, Xiong Z, Yan Y, Wang X, Nishino M, Mirkovic D, Nguyen J, Wang H, Yang X-F,. 2005. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 24 (30): 4778-4788. (Pubitemid 41076295)
75. Yoon S, Ha H-J, Kim Y-H, Won M, Park M, Ko J-J, Lee K, Bae J,. 2009. IEX-1-induced cell death requires BIM and is modulated by MCL-1. Biochem Biophys Res Commun 382 (2): 400-404.
76. Youle RJ, Strasser A,. 2008. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9 (1): 47-59.
77. Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Pawlowski K, Godzik A, Reed JC,. 2000. BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA 97 (6): 2597-2602. (Pubitemid 30159216)
78. Zhong Q, Gao W, Du F, Wang X,. 2005. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121 (7): 1085-1095. (Pubitemid 40884398)